Loading clinical trials...
Loading clinical trials...
Mitral valve prolapse (MVP) is a frequent affection of the mitral valve or its sub-valvular apparatus with a prevalence of 2-3% in the general population. This valvular disease is generally considered...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Central Hospital, Nancy, France
NCT07384871 · Mitral Valve Prolapse, Myxomatous Mitral Valve Degeneration
NCT06378996 · Mitral Valve Prolapse, Ventricular Arrythmia
NCT06255457 · Mitral Regurgitation, Mitral Valve Prolapse, and more
NCT07103733 · Mitral Valve Prolapse, Left Ventricular Fibrosis, and more
NCT04852731 · Mitral Valve Prolapse
Nancy University Hospital, Department of Cardiology
Vandœuvre-lès-Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions